Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles
 

Open Access

Original Research



Factors related with relapse in male alcohol dependents: 12 months follow-up study

Cüneyt Evren, Mine Durkaya, Ercan Dalbudak, Selime Çelik, Rabia Çetin, Duran Çakmak.

Abstract
Objective: Aim of this study was to evaluate clinical variables related with relapse to alcohol abuse during 12 months follow-up after inpatient treatment in male alcohol dependents. Method: Participants were 156 consecutively admitted male alcohol dependents. Among these patients, 102 were available at the evaluation that took place one year after the inpatient treatment. Patients were investigated with the Symptom Check List (SCL-90) and Michigan Alcoholism Screening Test (MAST) at baseline and with the PENN Alcohol Craving Scale (PACS) one year later, at follow-up. Results: Among 102 alcohol dependent inpatients, 61.8% (n=63) were considered as relapsed to alcohol abuse. Sociodemographic variables did not differ between groups. Mean scores of MAST and global severity index of SCL-90 did not differ significantly between groups, whereas craving score was higher in the relapsed group. Also the relapsed group had less polyclinic control, less attendance to the Outpatient Treatment Program (OTP), less changes in social environment for self protection and less use of anti-craving medications during one year follow-up. Severity of craving and not attending OTP during follow-up period predicted relapse in alcohol dependents. Conclusions: Severity of craving and not attending OTP seems to be the main factors related with relapse. Together with using anti-craving medications, regular attendance to OTP may help patients to recognize and manage with alcohol craving.

Key words: Alcohol dependence, craving, relapse, therapy



Article Language: Turkish English



Similar Articles

Paclitaxel-loaded magnetic nanocrystals for tumor neovascular-targeted theranostics: an amplifying synergistic therapy combining magnetic hyperthermia with chemotherapy.
Liu S, Shi D, Chen L, Yan Y, Wang X, Song Y, Pu S, Liang Y, Zhao Y, Zhang Y, Xie J
Nanoscale. 2021; 13(6): 3613-3626

A systematic literature review and meta-analysis of the clinical effects of aroma inhalation therapy on sleep problems.
Cheong MJ, Kim S, Kim JS, Lee H, Lyu YS, Lee YR, Jeon B, Kang HW
Medicine. 2021; 100(9): e24652

A Legal Right to Clozapine Therapy for Incarcerated Individuals With Treatment-Resistant Schizophrenia.
Zarzar TR, Williams JB, Pruette ME, Sheitman BB
Psychiatric services (Washington, D.C.). 2021; (): appips202000845

Gonadotropin releasing hormone analogue therapy in girls with idiopathic precocious puberty/early-fast puberty: dynamics in adiposity indices, eating habits and quality of life.
Loochi SA, Demol S, Nagelberg N, Lebenthal Y, Phillip M, Yackobovitch-Gavan M
Journal of pediatric endocrinology & metabolism : JPEM. 2021; ():

Promising phytochemicals of traditional Indian herbal steam inhalation therapy to combat COVID-19 - An in silico study.
Gowrishankar S, Muthumanickam S, Kamaladevi A, Karthika C, Jothi R, Boomi P, Maniazhagu D, Pandian SK
Food and chemical toxicology : an international journal published for the British Industrial Biolog. 2021; 148(): 111966

Prescription Patterns, Initiation, and 5-Year Adherence to Adjuvant Hormonal Therapy Among Commercially Insured Patients With Breast Cancer.
Zhao H, Lei X, Niu J, Zhang N, Duan Z, Chavez-MacGregor M, Giordano SH
JCO oncology practice. 2021; (): OP2000248

A fusion transcription factor-driven cancer progresses to a fusion-independent relapse via constitutive activation of a downstream transcriptional target.
Boudjadi S, Pandey PR, Chatterjee B, Nguyen TH, Sun W, Barr FG
Cancer research. 2021; ():

Practical Issues in the Use of Atezolizumab for Patients with Non-Small Cell Lung Cancer: Case Reports and Literature Review.
Cobo M, Rodríguez-Abreu D, Pérez Parente D, Ruiz Gracia P, González JG
Oncology and therapy. 2021; ():


Full-text options






Advertisement
American Journal of Diagnostic Imaging

SUBMIT YOUR ARTICLE NOW




ScopeMed.com
CancerLine
FoodsLine
PhytoMedline
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright © ScopeMed® Information Services.